The SELECT cardiovascular outcomes trial (N=17,604), published in NEJM 2023 (DOI: 10.1056/NEJMoa2307563), demonstrated a 20% reduction in major adverse cardiovascular events (MACE) -- the composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke -- in overweight or obese adults without diabetes
Tonum publishes trial summaries and resources that explain how different oral and prescription options compare
Methotrexate and psoriasis: consensus conference
Advanced Analysis Recognized as the most advanced and accurate test for assessing hormonal imbalances, its a valuable resource for health providers and their clients alike
Modern research attributes excessive adiposity to dysfunctions in satiety hormone signaling and central nervous system (CNS) feeding centers (10)
It isn't the same thing, and the distinction is worth keeping in mind as you read the rest of the marketing